zirconium has been researched along with transforming growth factor beta in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cenni, E; Granchi, D; Pizzoferrato, A; Vancini, M | 1 |
| Arlotti, M; Brunelli, G; Carinci, F; Guerzoni, L; Lo Muzio, L; Martinelli, M; Palmieri, A; Pezzetti, F; Rubini, C; Scapoli, L; Scarano, A | 1 |
| Dard, M; Freilich, M; Kuhn, L; Ortiz, D; Pendrys, D; Schleier, P; Shafer, D; Wen, B | 1 |
| Arjaans, ME; de Vries, EG; Gregory, RC; Hesselink, JW; Lub-de Hooge, MN; Oude Munnink, TH; Reiss, M; Schröder, CP; Timmer-Bosscha, H; Vedelaar, SR; Walenkamp, AM | 1 |
| Han, JS; Kim, DJ; Kim, SH; Lee, BC; Lee, JB; Yeo, IS | 1 |
| Bensch, F; Cees de Groot, J; de Vries, EG; den Dunnen, WF; den Hollander, MW; Enting, RH; Gietema, JA; Glaudemans, AW; Heesters, MA; Kruyt, FA; Lub-de Hooge, MN; Oude Munnink, TH; Pearlberg, J; Walenkamp, AM | 1 |
| Graf, HL; Kaluđerović, MR; Kohlweyer, H; Mändl, S | 1 |
| Cao, G; Li, Q; Quan, R; Shao, R; Shi, Y; Xie, S; Yang, D; Zhang, L; Zhuang, W | 1 |
| Du, WB; Jia, GY; Lv, LB; Quan, RF; Shao, RX; Wang, D; Wang, JF; Wang, T; Wei, XC; Xu, CY; Yang, DS | 1 |
1 trial(s) available for zirconium and transforming growth factor beta
| Article | Year |
|---|---|
TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with 89Zr-Fresolimumab PET.
Topics: Adult; Aged; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Brain Neoplasms; Cell Line, Tumor; Female; Glioma; Humans; Male; Metabolic Clearance Rate; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Tissue Distribution; Transforming Growth Factor beta; Zirconium | 2015 |
8 other study(ies) available for zirconium and transforming growth factor beta
| Article | Year |
|---|---|
Platelet release of transforming growth factor-beta and beta-thromboglobulin after in vitro contact with acrylic bone cements.
Topics: Acrylic Resins; Barium Sulfate; Benzoyl Peroxide; beta-Thromboglobulin; Biocompatible Materials; Blood Platelets; Bone Cements; Humans; Methylmethacrylates; Plasma; Platelet Activation; Polymethyl Methacrylate; Thrombosis; Time Factors; Transforming Growth Factor beta; Zirconium | 2002 |
Short-period effects of zirconia and titanium on osteoblast microRNAs.
Topics: Bone Morphogenetic Protein 4; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Carrier Proteins; Cartilage Oligomeric Matrix Protein; Cell Line, Transformed; Dental Porcelain; Extracellular Matrix Proteins; Gene Expression Profiling; Gene Expression Regulation; Glycoproteins; Humans; Matrilin Proteins; MicroRNAs; MSX1 Transcription Factor; Oligonucleotide Array Sequence Analysis; Osteoblasts; Osteogenesis; Protein Biosynthesis; Receptor, Fibroblast Growth Factor, Type 1; RNA Interference; Titanium; Transforming Growth Factor beta; Zirconium | 2008 |
Implant-guided vertical bone growth in the mini-pig.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Regeneration; Dental Abutments; Dental Implantation, Endosseous; Dental Implants; Dental Prosthesis Design; Mandible; Recombinant Proteins; Statistics, Nonparametric; Swine; Swine, Miniature; Tissue Scaffolds; Titanium; Transforming Growth Factor beta; Vertical Dimension; Wound Healing; X-Ray Microtomography; Zirconium | 2012 |
PET with the 89Zr-labeled transforming growth factor-β antibody fresolimumab in tumor models.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; Humans; Isotope Labeling; Liver; Male; Mice; Neoplasm Metastasis; Positron-Emission Tomography; Radioisotopes; Transfection; Transforming Growth Factor beta; Zirconium | 2011 |
Bone formation around zirconia implants combined with rhBMP-2 gel in the canine mandible.
Topics: Animals; Bone Morphogenetic Protein 2; Dental Implants; Dogs; Gels; Implants, Experimental; Mandible; Microscopy, Fluorescence; Osseointegration; Osteogenesis; Recombinant Proteins; Surface Properties; Titanium; Transforming Growth Factor beta; Zirconium | 2013 |
Physical vapour deposition of zirconia on titanium: fabrication, characterization and interaction with human osteoblast cells.
Topics: Cell Proliferation; Humans; Integrin-Binding Sialoprotein; Osteoblasts; Osteonectin; Titanium; Transforming Growth Factor beta; Zirconium | 2015 |
Evaluation of a Novel HA/ZrO2-Based Porous Bioceramic Artificial Vertebral Body Combined with a rhBMP-2/Chitosan Slow-Release Hydrogel.
Topics: Animals; Biocompatible Materials; Biomechanical Phenomena; Bone Morphogenetic Protein 2; Ceramics; Chitosan; Delayed-Action Preparations; Dogs; Drug Carriers; Durapatite; Humans; Hydrogels; Imaging, Three-Dimensional; Male; Osteogenesis; Porosity; Recombinant Proteins; Spine; Transforming Growth Factor beta; X-Ray Microtomography; Zirconium | 2016 |
Effects of a bone graft substitute consisting of porous gradient HA/ZrO
Topics: Animals; Biomechanical Phenomena; Bone and Bones; Bone Morphogenetic Protein 2; Bone Substitutes; Chitosan; Delayed-Action Preparations; Durapatite; Gelatin; Gene Expression Regulation; Hydrogels; Lumbar Vertebrae; Macaca mulatta; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Osseointegration; Osteogenesis; Porosity; Recombinant Proteins; Transforming Growth Factor beta; Wound Healing; X-Ray Microtomography; Zirconium | 2018 |